
More Startup Funding Under U.K. Industrial Plan
Leandros Kalisperas, Chief Investment Officer, British Business bank says the investment outlook is ... More positive
More public money is to be invested in startups and scaleups as part of the U.K. government's 'Modern Industrial Strategy,' which was unveiled this week. Under the plan, the publicly funded British Business Bank is to commit £4.0 billion of new capital to early-stage companies working in eight sectors identified as crucial to future economic prosperity. Meanwhile, an additional £2.6 billion will be available to promising startups across all industries.
Coinciding with the publication of the strategy document, the British Business Bank (BBB) has released its own research into investment patterns in 2024. The data shows that while private investment flooded into AI startups and scaleups last year, the U.K. trailed the U.S. in key sectors such as advanced manufacturing and life sciences. Thus, if Britain is to become a science-led superpower, then there is some catching up to do.
So, how does the British Business Bank see the investment outlook for Britain's technology startups, and what part will the institution play in supporting companies that have the potential to become global leaders? To find out, I spoke to Leandros Kalisperas and Matt Adey, respectively, Chief Investment Officer and Senior Economist at the BBB.
The bank's report presents a mixed picture of the investment landscape. On the debit side, funding declined by 2.0% to £10.8 billion while the number of deals fell by a much larger 15% to 2,048.
However, Kalisperas says, those figures have to be seen in context. 'Overall, it's positive,' he says. The value of deals was still the fifth highest on record.'
And as he points out, for those companies that successfully raised capital, deal sizes were on average larger. 'There was a small decline in percentage terms and a slightly higher decline in deal numbers. That means companies that are getting finance are getting more finance,' he adds.
AI Leads The Way
Perhaps not surprisingly, companies operating in the artificial intelligence space did particularly well in 2024. According to the report, AI-related deals averaged £8 million, 40% higher than the average in other sectors. This aligns neatly with the desire of policymakers to establish the U.K. as a leader in the field. 'AI is a growth priority, " says Kalisperas.
University spinouts also had a good year, collectively raising almost £2 billion. Again, this ties in neatly with the Industrial Strategy's aim of improving and accelerating the commercialisation of university research, something that the U.K. has not always done well.
'We do think this is absolutely critical given Britain's standing in the world. Commercialisation is the challenge, but the numbers speak for themselves in terms of the growth of that,' says Matt Adey.
Regions See More Investment
As Kalisperas sees it, rising investment in spinouts goes hand in hand with another theme of the report. Investment in Britain's regions is rising, a trend that is seeing London's share of the overall pot fall to 61%. This, he says, speaks to the success of companies emerging from university towns and cities outside London - and not just in and around Oxford and Cambridge.
'We talk about the golden triangle (Oxford, Cambridge, London) , but we are also seeing the development of the Northern Arc,' he says.
The eagerness of universities to spin out science-led companies is, to some extent, being matched by local investment trends. Angels are crucially important because they have a local presence and can spot the emergence of promising companies. There are also increasing numbers of VCs working locally. Kalisperas cites the example of Northern Gritstone, a fund specializing in science investment in the North of England.
Filling Funding Gaps
All of which bodes well for investment in sectors identified by the Industrial Strategy, but there are investment shortfalls. For instance, the report notes that advanced manufacturing and life sciences are both underfunded when compared to investment levels in the U.S.
'When you adjust for the size of the economy, we are behind the US. But we have some successful businesses, so we are building from a strong base. But we do need to get closer to the U.S. funding levels,' says Matt Adey. However, as he stresses, the U.K. is ahead in clean energy and financial technology.
That's where the BBB has an opportunity to play a key role in directing investment at strategically important industries. 'The Bank will get considerably more financial power. It is likel that we will be tasked with dealoing those gaps robustly,' says Kalisperas.
It would be wrong to suggest that the Modern Industrial Strategy is all about startups. The plan includes cheaper electricity prices for businesses, cheaper and faster grid connection to the power grid, measures to boost exports and more defence spending. There will also be increased investment in quantum computing through a £670 million funding package and five progams to increase the use of AI in the services sector
The initiative also sees the government putting more emphasis on promoting growth and innovation in the regions, a development welcomed by Aline Miller, Academic Innovation Lead at Manchester innovation district, Sister. 'This strategic pivot - placing greater emphasis on regional strengths outside the Golden Triangle - marks a needed shift towards a more balanced, inclusive model of national growth,' she said.
Meanwhile, the enhanced financial power given to the BBB as part of the financial Strategy will give the bank a greater role in providing strategic funding across all the key sectors, such as life sciences, defence, digital technology and clean energy.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
GoNetZero™ and AlliedOffsets Partner to Help Businesses Navigate the Voluntary Carbon Market with Confidence
SINGAPORE and LONDON, June 25, 2025 /PRNewswire/ -- GoNetZero™, a global decarbonisation enabler in clean energy procurement and carbon management, announces a new strategic alliance with AlliedOffsets, the world's leading carbon market intelligence provider, to help businesses navigate the voluntary carbon market (VCM) with greater transparency, insight, and confidence. This partnership brings together GoNetZero's curated portfolio of verified carbon credits with AlliedOffsets' analytics platform, which tracks over 34,000 carbon projects globally. By uniting market access with deep data insights, the collaboration aims to help organisations navigate evolving VCM dynamics and make smarter, data-driven decisions that drive meaningful climate impact. "As organisations face growing pressure to back their climate claims with credible action, transparency and data have become essential," said Soon Sze Meng, CEO of GoNetZero. "This partnership will bring together GoNetZero's portfolio of verified carbon credits with AlliedOffsets' market intelligence, helping our clients evaluate carbon offsetting projects with greater clarity and confidence. It's about empowering organisations to make informed choices and drive impact at scale." Through this collaboration, GoNetZero's clients will gain deeper insights into VCM fundamentals – including pricing trends, issuance pipelines, co-benefit preferences, and buyer activity, helping them make better-informed procurement decisions. These insights will also enable clients to benchmark their offsetting and removal strategies against industry peers, enhancing both rigour and credibility in their corporate sustainability efforts. "GoNetZero and AlliedOffsets offer an end-to-end solution for companies that are looking to deliver high-integrity climate impact," said Anton Root, Co-founder at AlliedOffsets. "We're proud to be working with a partner like GoNetZero that shares our vision for a transparent carbon market." This collaboration also supports wider ecosystem engagement by creating more opportunities for dialogue, knowledge sharing, and alignment across the carbon value chain. In the autumn of 2025, GoNetZero and AlliedOffsets will co-host an Industry Day to convene carbon market participants, facilitate dialogue, and accelerate progress. Additionally, the two companies will launch a joint content series designed to guide emissions-intensive sectors on: Sector-specific trends across energy and technology/ telecoms. How to align carbon offsetting strategies with broader ESG goals, regulatory developments, and stakeholder expectations. How to identify high-integrity credits aligned with tightening VCM standards. For more information, visit and Media contact: press@ / Commercial contact: connect@ / hello@ View original content to download multimedia: SOURCE GoNetZero™ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
41 minutes ago
- Bloomberg
HDB Starts Taking Orders for One of Year's Biggest India IPOs
HDB Financial Services Ltd. began taking orders for one of India's biggest initial public offerings this year, in a deal that may fetch 125 billion rupees ($1.5 billion) as the shadow lender seeks to benefit from the recent rally in stock prices. The shares are being marketed from Wednesday at 700 rupees to 740 rupees each, valuing the company at as much as $7 billion. The company plans to take orders until Friday.
Yahoo
an hour ago
- Yahoo
Top Analyst Reports for JPMorgan, Novartis & AT&T
Tuesday, June 24, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Novartis AG (NVS) and AT&T Inc. (T), as well as two micro-cap stocks Perma-Pipe International Holdings, Inc. (PPIH) and Utah Medical Products, Inc. (UTMD). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the research reports have been hand-picked from the roughly 70 reports published by our analyst team can see all of today's research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each can read today's AWS here >>> Home Prices Drop, Fed Chair on Capitol Hill TodayToday's Featured Research ReportsJPMorgan's shares have outperformed the Zacks Financial - Investment Bank industry over the past year (+43.2% vs. +36.2%). The company's business expansion efforts, decent loan demand and relatively high rates will support net interest income (NII) growth. We expect NII (managed) to show a CAGR of 2.2% by 2027. While a solid resurgence in deal-making activities is likely to take time, a solid pipeline will drive the investment banking (IB) business. The Zacks analyst expect IB fees to witness a CAGR of 1.6% by 2027. Yet, the volatile nature of the capital markets business and high mortgage rates will hurt fee income growth. Our estimate for non-interest income (reported) shows a 6.9% fall in 2025. As the company invests in technology and marketing, expenses are expected to remain elevated. Our estimates for non-interest expenses imply a CAGR of 2.1% by 2027. Weakening asset quality is another major concern.(You can read the full research report on JPMorgan here >>>)Shares of Novartis have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+12.4% vs. -16.7%). The company maintains strong momentum on the back of a strong and diverse portfolio with drugs like Kisqali, Kesimpta, Pluvicto and Leqvio. The uptake of Pluvicto and Scemblix has been outstanding and propels top-line growth. The Zacks model estimates for Pluvicto and Kisqali indicate a CAGR of 29.6% and 34.3%, respectively, over the next three years. Approval of new drugs and label expansion of existing drugs should enable Novartis to offset the adverse impacts of the generic competition for key drugs. The recent spate of acquisitions and collaborations has further strengthened its pipeline. Concurrent with the first-quarter results, management raised its guidance for 2025. However, one of the top drugs, Entresto, is likely to lose patent protection. This, in turn, may adversely impact sales. (You can read the full research report on Novartis here >>>)AT&T's shares have outperformed the Zacks Wireless National industry over the past year (+59.1% vs. +28.3%). The company expects to continue investing in key areas and adjust its business according to the evolving market scenario to fuel long-term growth. With a customer-centric business model, AT&T is witnessing healthy momentum in its postpaid wireless business with a lower churn rate and increased adoption of higher-tier unlimited plans. AT&T has collaborated with Microsoft to move its 5G mobile network to the latter's cloud. This will enable the company to enhance productivity and deliver large-scale network services to meet customers' needs. However, the company's wireline division is struggling with persistent losses in access lines as a result of competitive pressure from voice-over-Internet protocol (VoIP) service providers. Healthy discounts and freebies to woo customers dent margins. The high debt burden remains a concern.(You can read the full research report on AT&T here >>>)Shares of Perma-Pipe International have outperformed the Zacks Steel - Pipe and Tube industry over the year-to-date period (+57.2% vs. -0.1%). This microcap company with market capitalization of $187.67 million is benefiting from strong global tailwinds, including rising infrastructure investment, urbanization and energy efficiency demand. Its geographic reach across MENA, Southeast Asia, and the Americas enables access to high-growth sectors such as district energy, oil & gas, and pharmaceuticals. Backlog expanded 33% to over $100 million, driven by major wins like a $43 million GCC contract and a $2.4 million Qatar project, where the company is also building a permanent facility. Q1 FY25 saw sales rise 36% YoY, gross margins expand to 36%, and net income more than triple to $5 million. However, the company remains exposed to cyclical end markets such as oil & gas and construction, which are sensitive to economic slowdowns and project delays. Shares have surged 164% over the past year and continue to trade at a discount to peers on EV/EBITDA and EV/sales metrics.(You can read the full research report on Perma-Pipe International here >>>)Utah Medical Products' shares have underperformed the Zacks Medical - Products industry over the past year (-9.8% vs. +5.1%). This microcap company with market capitalization of $178.29 million has risks consisting of: OEM dependence (PendoTECH accounted for 91% of the 1Q25 decline), regulatory headwinds and underutilized CapEx depress asset returns. Geopolitical tariff uncertainty and rising compliance costs add further pressure. Shares have fallen 10.7% YTD, now trading at 2.47X EV/sales compared with the sub-industry's 6.24X. Nevertheless, UTMD remains strategically positioned in women's and neonatal health, with resilient product demand and geographic diversification cushioning policy and currency risks. Despite a 14.4% YoY revenue drop in 1Q25, direct device sales grew 11.6%, highlighting demand strength in NICU devices. The firm operates with a high-margin, globally recognized specialty device portfolio, sustaining a 57% gross margin. UTMD's in-house manufacturing supports cost control, while a debt-free balance sheet and $83.3 million in cash provide flexibility for shareholder returns and reinvestment.(You can read the full research report on Utah Medical Products here >>>)Other noteworthy reports we are featuring today include NextEra Energy, Inc. (NEE), Amphenol Corp. (APH) and Johnson Controls International plc (JCI).Mark VickerySenior EditorNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Branch Expansion to Aid JPMorgan (JPM) Amid Fee Income Woes Kisqali, Pluvicto Drive Novartis (NVS) Amid Competition AT&T (T) Rides on Solid Wireless Momentum, Fiber Expansion Featured Reports NextEra (NEE) Gains from Renewable Focus, Steady InvestmentPer the Zacks analyst, NextEra's planned long-term investment to enhance clean electricity generation and strengthen its infrastructure will boost its profitability. End-Market Strength & Diversification Aids Amphenol (APH)Per the Zacks analyst, Amphenol benefits from a diversified business model that lowers volatility of individual geographies. HVAC & Controls Aids Johnson Controls (JCI) Amid Forex WoesPer the Zacks analyst, continued demand for HVAC & Controls within the Building Solutions North America segment is likely to drive Johnson Controls' revenues. However, forex woes remain a concern. lululemon's (LULU) International Business Well Poised for GrowthPer the Zacks analyst, lululemon witnesses strong business momentum in international markets, including Mainland China and the Rest of the World, as the brand connects well with customers globally. Investments Aid Edison International (EIX), Rising Costs AilPer the Zacks analyst, systematic capital investment boosts Edison International's infrastructure and customer reliability. Yet, rising wildfire related charges might hurt its bottom line. YPF's Progress in Vaca Muerta Shale Drives Production SurgeYPF's shift from mature fields to shale oil operations in Vaca Muerta is set to increase production and drive profitability. However, the rise in its net leverage ratio concerns the Zacks analyst. NMI Holdings (NMIH) Banks on Solid Mortgage Insurance Market Per the Zacks analyst, NMI Holdings gains from mortgage insurance market riding on well performing primary insurance-in-force, which drives new insurance written. However, high costs remain a concern. New Upgrades Jabil (JBL) Benefits from Healthy Demand, Product InnovationPer the Zacks analyst, solid demand in digital commerce, cloud and AI data center infrastructure markets will likely drive Jabil's top line. A strong focus on innovation is a tailwind. Expansion Strategies, Solid Liquidity Aid Federated (FHI)Per the Zacks Analyst, the focus on acquiring money market assets will drive Federated's revenues and asset under management AUM. Solid liquidity position aids capital distribution activities. Upbound (UPBD) Accelerates Growth With Acima, Brigit GainsPer the Zacks analyst, Upbound's virtual LTO business, Acima, saw 8.8% GMV growth in the first quarter of 2025, while Brigit posted 35% revenue growth post-acquisition. New Downgrades Increasing Costs & Forex Woes Hurt Zebra Technologies (ZBRA)Per the Zacks analyst, Zebra Technologies' steady revenue growth and operational efficiencies are being dampened by a steep rise in cost of sales. Also, foreign currency headwinds are concerning. UroLift Woes, Macroeconomic Pressures Hurt Teleflex (TFX)The Zacks analyst is concerned with Teleflex's UroLift product line persistently facing end-market headwinds within the U.S. office site of service. High costs from macroeconomic woes remain a drag. Still-High Mortgage Rates & Macro Risks Hurt NVR's ProspectsPer the Zacks analyst, NVR's growth is hindering from the ongoing affordability issues in the housing market due to the still-high mortgage rates, lingering inflation and tariff-related risks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report JPMorgan Chase & Co. (JPM) : Free Stock Analysis Report NextEra Energy, Inc. (NEE) : Free Stock Analysis Report Novartis AG (NVS) : Free Stock Analysis Report AT&T Inc. (T) : Free Stock Analysis Report Johnson Controls International plc (JCI) : Free Stock Analysis Report Amphenol Corporation (APH) : Free Stock Analysis Report Utah Medical Products, Inc. (UTMD): Free Stock Analysis Report Perma-Pipe International Holdings, Inc. (PPIH): Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data